U of T's Janet Rossant named one of five L’Oréal-UNESCO outstanding women in science
One of Canada’s leading stem cell researchers, Professor Janet Rossant, will be honoured by UNESCO and the L'Oréal Foundation as one of five outstanding female scientists from around the world.
Register at: https://www.cvent.com/events/cell-gene-therapies-101/registration-5c43450eb0aa417e80dd2d55542ab792.aspx?fqp=true
Careers | Centre for Commercialization of Regenerative Medicine | Article
Role Summary: We are seeking a Manager, Commercialization. You will be the point person for providing and coordinating customized commercialization advice and support to university-based Principal I...
Business of Regenerative Medicine
CCRM and the Rotman School of Management present the 10th annual Business of Regenerative Medicine, in partnership with Case Western Reserve University, the Harvard Stem Cell Institute and the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech. This 2.5 day workshop will include lectures delivered by established scientific and industry leaders, panel discussions, case study analysis, competitions, networking events and more.
How the discovery of stem cells revolutionized medicine
Canadians James Till and Ernest McCulloch discovered stem cells in 1961, and their seminal research laid the foundation for regenerative medicine and the biomedical industry
Versant Ventures and Bayer AG dedicate $295 million to stem cell therapy company with operations in Toronto
BlueRock Therapeutics is a stem cell company that will work in collaboration with institutions from Canada, the US, and Japan.
Making connections - advancing regenerative medicine through partnerships - Signals Blog
A key driver for advancements in regenerative medicine is partnerships. In recognition of this, every year CCRM hosts a networking reception that brings together our partners for an evening of discussion and knowledge sharing. This year's industry networking reception was focused on the theme of increasing partnerships between industry and academia.
The Drug of the Future: Cells
Bioengineers are seeking to manufacture enough stem cells to make therapies viable, with big potential payoffs in fighting disease. READ MORE: http://researc...
JDRF Funds U of T Engineering Research to Improve Cell Transplantation to Treat Type 1 Diabetes
TORONTO, ON--(Marketwired - October 12, 2016) - JDRF and the University of Toronto are supporting research that will help improve islet transplantation and make the procedure more widely available for patients living with type 1 diabetes (T1D).U of T Engineering Professor Michael Sefton was awarded $1.1 million ($845,135 USD) to...
Hydrogel Successfully Delivers Stem Cells to the Brain and Eye, Restoring Vision by 15%
Molly Shoichet, Canada Research Chair in Tissue Engineering at the University of Toronto, is a leader in the use of biomaterials to enhance cell delivery and to guide stem cell fate for tissue engineering, ...
Molly Shoichet awarded 2016 Till & McCulloch Award
University Professor Molly Shoichet, a world-renowned researcher and leader in the use of biomaterials to enhance stem-cell delivery for treating disease conditions from stroke to blindness, is the recipient of the 2016 Till & McCulloch Award.